greeksoup/ stock research
Stock research / United States / BIIB / FY2007

Biogen (BIIB) FY2007 results: revenue $3.2 billion

Biogen Inc. (BIIB) reported revenue of $3.2 billion for fiscal 2007, the year ended 31 December 2007. Net income was $638 million, and diluted earnings per share $1.99. The figures are the company's own, from the 10-K it filed with the SEC on 9 February 2010.

Revenue
$3.2 billion
FY2007FY2007
Operating margin
24.6%
FY2007FY2007
Net income
$638 million
FY2007FY2007
Diluted EPS
$1.99
FY2007FY2007

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2007Last 8 years
Revenue3,172
Cost of revenue335
Gross profit2,836
Gross margin89.4%
Research and development925
Selling, general and administrative776
Operating income780
Operating margin24.6%
Pre-tax income852
Income tax272
Effective tax rate32.0%
Net income638
Net margin20.1%
Diluted EPS$1.99
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2007Last 8 years
Operating cash flow1,019
Capital expenditure284
Free cash flow735
Free cash flow margin23.2%
Cash from investing-287
Cash from financing-733
Depreciation and amortisation380
Share-based compensation123
Buybacks2,991
Diluted shares, weighted320m

Balance sheet

$ millionFY2007Last 8 years
Shareholders' equity5,554
Cash and equivalents660

10-K for the year ended 31 December 2007, filed 9 February 2010: the filing.